Lynsey Mukomel
LANSING – Michigan Attorney General Dana Nessel announced today that Michigan will receive more than $4 million in a settlement agreement involving Indivior PLC and Indivior Inc. (Indivior).
This settlement covers six federal lawsuits and involves Indivior’s product Suboxone, a buprenorphine drug that was approved for use by recovering opioid addicts to avoid or reduce withdrawal symptoms while they undergo treatment.
Allegations detailed in lawsuits assert that, from 2010 through 2015, Indivior: promoted the sale and use of the drug to physicians who were writing prescriptions without having a medical purpose; knowingly promoted Suboxone Sublingual Film based on false and misleading claims that it was less subject to diversion and abuse than other buprenorphine products and less susceptible to accidental pediatric exposure than Suboxone Sublingual Tablets; and
SOM
AG Nessel Announces $300 Million Multistate Settlement with Suboxone MakerContact: Lynsey Mukomel 517-599-2746Agency: Attorney General
April 29, 2021
LANSING - Michigan Attorney General Dana Nessel announced today that Michigan will receive more than $4 million in a settlement agreement involving Indivior PLC and Indivior Inc. (Indivior).
This settlement covers six federal lawsuits and involves Indivior s product Suboxone, a buprenorphine drug that was approved for use by recovering opioid addicts to avoid or reduce withdrawal symptoms while they undergo treatment.
Allegations detailed in lawsuits assert that, from 2010 through 2015, Indivior:
promoted the sale and use of the drug to physicians who were writing prescriptions without having a medical purpose;